177 related articles for article (PubMed ID: 27356987)
1. NMR backbone resonance assignment and solution secondary structure determination of human NSD1 and NSD2.
Amin N; Nietlispach D; Qamar S; Coyle J; Chiarparin E; Williams G
Biomol NMR Assign; 2016 Oct; 10(2):315-20. PubMed ID: 27356987
[TBL] [Abstract][Full Text] [Related]
2. In vitro histone lysine methylation by NSD1, NSD2/MMSET/WHSC1 and NSD3/WHSC1L.
Morishita M; Mevius D; di Luccio E
BMC Struct Biol; 2014 Dec; 14():25. PubMed ID: 25494638
[TBL] [Abstract][Full Text] [Related]
3. Structural insights into the regulation and the recognition of histone marks by the SET domain of NSD1.
Morishita M; di Luccio E
Biochem Biophys Res Commun; 2011 Aug; 412(2):214-9. PubMed ID: 21806967
[TBL] [Abstract][Full Text] [Related]
4. Backbone resonance assignments for the SET domain of the human methyltransferase NSD2.
Bobby R; Peciak K; Milbradt AG
Biomol NMR Assign; 2016 Oct; 10(2):307-10. PubMed ID: 27368234
[TBL] [Abstract][Full Text] [Related]
5. Cancers and the NSD family of histone lysine methyltransferases.
Morishita M; di Luccio E
Biochim Biophys Acta; 2011 Dec; 1816(2):158-63. PubMed ID: 21664949
[TBL] [Abstract][Full Text] [Related]
6. A Basic Post-SET Extension of NSDs Is Essential for Nucleosome Binding In Vitro.
Allali-Hassani A; Kuznetsova E; Hajian T; Wu H; Dombrovski L; Li Y; Gräslund S; Arrowsmith CH; Schapira M; Vedadi M
J Biomol Screen; 2014 Jul; 19(6):928-35. PubMed ID: 24595546
[TBL] [Abstract][Full Text] [Related]
7. The NSD family of protein methyltransferases in human cancer.
Vougiouklakis T; Hamamoto R; Nakamura Y; Saloura V
Epigenomics; 2015 Aug; 7(5):863-74. PubMed ID: 25942451
[TBL] [Abstract][Full Text] [Related]
8. Identification of LEM-14 inhibitor of the oncoprotein NSD2.
Shen Y; Morishita M; Lee D; Kim S; Lee T; Mevius DEHF; Roh Y; di Luccio E
Biochem Biophys Res Commun; 2019 Jan; 508(1):102-108. PubMed ID: 30471851
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of NSD2 and NSD3 in overgrowth syndromes.
Douglas J; Coleman K; Tatton-Brown K; Hughes HE; Temple IK; Cole TR; Rahman N;
Eur J Hum Genet; 2005 Feb; 13(2):150-3. PubMed ID: 15483650
[TBL] [Abstract][Full Text] [Related]
10. High yield recombinant expression and purification of oncogenic NSD1, NSD2, and NSD3 with human influenza hemagglutinin tag.
Shen Y; Morishita M; di Luccio E
Protein Expr Purif; 2020 Feb; 166():105506. PubMed ID: 31563542
[TBL] [Abstract][Full Text] [Related]
11. The methyltransferase NSD3 has chromatin-binding motifs, PHD5-C5HCH, that are distinct from other NSD (nuclear receptor SET domain) family members in their histone H3 recognition.
He C; Li F; Zhang J; Wu J; Shi Y
J Biol Chem; 2013 Feb; 288(7):4692-703. PubMed ID: 23269674
[TBL] [Abstract][Full Text] [Related]
12. NUP98-NSD1 links H3K36 methylation to Hox-A gene activation and leukaemogenesis.
Wang GG; Cai L; Pasillas MP; Kamps MP
Nat Cell Biol; 2007 Jul; 9(7):804-12. PubMed ID: 17589499
[TBL] [Abstract][Full Text] [Related]
13. Nizp1, a novel multitype zinc finger protein that interacts with the NSD1 histone lysine methyltransferase through a unique C2HR motif.
Nielsen AL; Jørgensen P; Lerouge T; Cerviño M; Chambon P; Losson R
Mol Cell Biol; 2004 Jun; 24(12):5184-96. PubMed ID: 15169884
[TBL] [Abstract][Full Text] [Related]
14. The role of NSD1, NSD2, and NSD3 histone methyltransferases in solid tumors.
Topchu I; Pangeni RP; Bychkov I; Miller SA; Izumchenko E; Yu J; Golemis E; Karanicolas J; Boumber Y
Cell Mol Life Sci; 2022 May; 79(6):285. PubMed ID: 35532818
[TBL] [Abstract][Full Text] [Related]
15. Histone and DNA binding ability studies of the NSD subfamily of PWWP domains.
Zhang M; Yang Y; Zhou M; Dong A; Yan X; Loppnau P; Min J; Liu Y
Biochem Biophys Res Commun; 2021 Sep; 569():199-206. PubMed ID: 34271259
[TBL] [Abstract][Full Text] [Related]
16. The structure of NSD1 reveals an autoregulatory mechanism underlying histone H3K36 methylation.
Qiao Q; Li Y; Chen Z; Wang M; Reinberg D; Xu RM
J Biol Chem; 2011 Mar; 286(10):8361-8368. PubMed ID: 21196496
[TBL] [Abstract][Full Text] [Related]
17. Role for the nuclear receptor-binding SET domain protein 1 (NSD1) methyltransferase in coordinating lysine 36 methylation at histone 3 with RNA polymerase II function.
Lucio-Eterovic AK; Singh MM; Gardner JE; Veerappan CS; Rice JC; Carpenter PB
Proc Natl Acad Sci U S A; 2010 Sep; 107(39):16952-7. PubMed ID: 20837538
[TBL] [Abstract][Full Text] [Related]
18. Structure of the Epigenetic Oncogene MMSET and Inhibition by N-Alkyl Sinefungin Derivatives.
Tisi D; Chiarparin E; Tamanini E; Pathuri P; Coyle JE; Hold A; Holding FP; Amin N; Martin AC; Rich SJ; Berdini V; Yon J; Acklam P; Burke R; Drouin L; Harmer JE; Jeganathan F; van Montfort RL; Newbatt Y; Tortorici M; Westlake M; Wood A; Hoelder S; Heightman TD
ACS Chem Biol; 2016 Nov; 11(11):3093-3105. PubMed ID: 27571355
[TBL] [Abstract][Full Text] [Related]
19. Backbone resonance assignments for the SET domain of human methyltransferase NSD3 in complex with its cofactor.
Li Y; Ng HQ; Ngo A; Liu S; Tan YW; Kwek PZ; Hung AW; Joy J; Hill J; Keller TH; Kang C
Biomol NMR Assign; 2017 Oct; 11(2):225-229. PubMed ID: 28808922
[TBL] [Abstract][Full Text] [Related]
20. The Role of Nuclear Receptor-Binding SET Domain Family Histone Lysine Methyltransferases in Cancer.
Bennett RL; Swaroop A; Troche C; Licht JD
Cold Spring Harb Perspect Med; 2017 Jun; 7(6):. PubMed ID: 28193767
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]